Almasry Pharmacy

Seretide 50 / 25 Mcg 120 Doses Evohaler

Short Description:
Seretide 50 / 25 mcg Evohaler is a combination maintenance inhaler for asthma and COPD, providing anti‑inflammatory and long‑acting bronchodilator action in one device. With 120 metered doses, it helps control symptoms, improve lung function, and reduce asthma attacks when used regularly as prescribed.

EGP 205EGP 219

In Stock

delivery-iconDelivery to governorates within 3-4 working days
refund-iconEasy returns within 14 days
Specifications
SKUISG008239
BrandSeretideLink Icon
Categories
Medication & Treatments
Color
black
Shop by ConcernsAsthmaLink Icon, Chest DiscomfortLink Icon, COPDLink Icon, Shortness of BreathLink Icon, WheezingLink Icon
Gender
Unisex
Shop By GoalsAsthma ControlLink Icon, Cough SupportLink Icon, Improved BreathingLink Icon, Prevention of Asthma AttacksLink Icon
Ingredient
Fluticasone
Salmeterol xinafoate
Specialty
Clinically Tested
Long Acting
Prescription only
Sub Categories
Asthma
Warning
Diabetes
hyperthyroidism
May cause oral thrush
Not for acute conditions
Use under medical supervision
Use With Caution in Heart Disease
About the product

Seretide 50 / 25 mcg 120 Doses Evohaler

Description:

Seretide 50 / 25 mcg Evohaler is a prescription combination asthma inhaler containing an inhaled corticosteroid and a long-acting bronchodilator. It is designed for regular maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD), helping to control inflammation in the airways and keep them open for easier breathing. This metered-dose inhaler delivers 120 actuations (puffs), each containing a fixed dose of fluticasone propionate and salmeterol xinafoate to reduce asthma symptoms such as wheezing, chest tightness, and shortness of breath, and to help prevent asthma attacks when used daily as prescribed.


Indications:

  • Maintenance treatment of asthma in patients who require a combination of inhaled corticosteroid and long-acting beta2-agonist (LABA).
  • Control and prevention of asthma symptoms including wheezing, coughing, chest tightness, and shortness of breath.
  • Reduction of the frequency and severity of asthma exacerbations when used regularly.
  • Maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, in patients where a combination of inhaled corticosteroid and LABA is indicated (as per physician’s judgment).

Active Ingredients / Key Components:

  • Fluticasone propionate – 50 mcg per actuation (inhaled corticosteroid; anti‑inflammatory).
  • Salmeterol xinafoate – 25 mcg per actuation (long‑acting beta2-adrenergic agonist; bronchodilator).
  • Each Evohaler provides 120 metered doses (actuations).
  • Other (inactive) ingredients: Exact propellants and excipients are not specified in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.); full excipient list is not available.

Dosage & Administration / How to Use:

  • Use Seretide Evohaler exactly as prescribed by your doctor. Do not change the dose or frequency without medical advice.
  • Typical adult and adolescent dosing (for guidance only – always follow your prescription): usually 2 inhalations per day (for example, 1 inhalation twice daily). Exact regimen must be determined by a healthcare professional.
  • This is a maintenance (controller) inhaler and must be used regularly every day, even if you have no symptoms. It is not intended for immediate relief of acute asthma attacks.
  • How to use the Evohaler:
    • 1. Remove the mouthpiece cover and check that the mouthpiece is clean and free from dust or particles.
    • 2. Shake the inhaler well before each use.
    • 3. Breathe out gently, away from the inhaler, to empty your lungs (do not exhale into the device).
    • 4. Place the mouthpiece between your teeth and close your lips around it, ensuring a good seal. Do not bite.
    • 5. Start to breathe in slowly and deeply through your mouth, and at the same time press down firmly on the canister to release one puff.
    • 6. Continue to inhale steadily and deeply, then remove the inhaler from your mouth and hold your breath for about 10 seconds or as long as comfortable.
    • 7. Breathe out slowly.
    • 8. If a second puff is prescribed, wait about 30 seconds to 1 minute, then repeat the steps above.
  • After use, replace the mouthpiece cover firmly.
  • Rinse your mouth with water and spit out after each dose to help reduce the risk of oral thrush and hoarseness.
  • Do not use as a rescue inhaler for sudden breathing problems; use a fast-acting reliever (short-acting beta2-agonist) prescribed by your doctor for acute attacks.
  • If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. Do not double the dose to make up for a missed one.

Clinical Benefits:

  • Provides dual action control of asthma by combining anti‑inflammatory (fluticasone) and long‑acting bronchodilator (salmeterol) in one inhaler.
  • Helps reduce airway inflammation, swelling, and hyper‑responsiveness, leading to better long‑term asthma control.
  • Maintains bronchodilation for up to 12 hours, improving airflow and making breathing easier throughout the day and night.
  • Reduces frequency and severity of asthma exacerbations when used regularly as prescribed.
  • Improves overall lung function and helps decrease day‑time and night‑time asthma symptoms such as wheezing and chest tightness.
  • Convenient fixed-dose combination in a single Evohaler, supporting better adherence to treatment.

Warnings & Contraindications:

  • Seretide Evohaler is a prescription medicine and should only be used under the supervision of a healthcare professional.
  • Do not use this inhaler to treat sudden asthma attacks or acute episodes of breathlessness. A short‑acting reliever inhaler (such as salbutamol) should be used for immediate relief.
  • Contraindicated in patients with known hypersensitivity or allergy to fluticasone, salmeterol, or any of the excipients in the formulation.
  • Use with caution in patients with cardiovascular diseases (such as ischemic heart disease, arrhythmias, or hypertension), hyperthyroidism, diabetes mellitus, or a history of seizures.
  • Long‑term use of high-dose inhaled corticosteroids may be associated with systemic effects such as adrenal suppression, decreased bone mineral density, cataract, or glaucoma; use the lowest effective dose.
  • Patients with active or latent pulmonary infections (including tuberculosis) should be monitored carefully when using inhaled corticosteroids.
  • Do not stop using Seretide suddenly without consulting your doctor, as this may worsen asthma control.
  • Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding. Your doctor will weigh the benefits and potential risks.
  • Inform your doctor about all medications you are taking, especially other inhalers, beta‑blockers, antifungals (e.g., ketoconazole), antivirals, or systemic corticosteroids, due to potential interactions.
  • Not intended to diagnose, treat, cure, or prevent any disease outside its approved indications.
  • Keep out of reach of children.

Side Effects:
  • Common side effects: oral thrush (fungal infection in the mouth), hoarseness or voice changes, throat irritation, cough after inhalation, headache, and mild tremor or palpitations.
  • Less common side effects: muscle cramps, joint pain, nervousness, rapid heartbeat, or dizziness.
  • Possible corticosteroid-related effects (especially with prolonged high doses): bruising, slowed growth in children and adolescents, decreased bone mineral density, cataract, or increased intraocular pressure.
  • Allergic reactions (rare but serious): rash, itching, swelling of the face, lips, tongue, or throat, severe dizziness, or trouble breathing. Seek immediate medical attention if these occur.
  • If you experience worsening breathing, paradoxical bronchospasm (sudden wheezing or shortness of breath immediately after use), or no improvement in symptoms, stop using the inhaler and seek urgent medical advice.

Storage Instructions:

Store in a cool, dry place away from direct sunlight and heat sources. Do not expose the canister to temperatures above 30°c or to freezing. Do not puncture, break, or burn the canister, even when it appears empty. Keep the mouthpiece clean and dry, and always replace the mouthpiece cover after use. Keep out of reach of children.


Specifications:
  • Product type: prescription asthma and COPD maintenance medicine (inhaler).
  • Form: metered-dose Evohaler (pressurized inhalation device).
  • Strength: 50 mcg fluticasone propionate + 25 mcg salmeterol xinafoate per actuation.
  • Content: 120 metered doses (puffs) per inhaler.
  • Intended users: adults and children as directed by a physician (age limits and dosing to be determined by the doctor).

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.

More fromSeretide

See More

Product Reviews

Overall Rating
0

Based on 0 reviews

Warning iconYou can add a rating once you purchase the product through the My Orders page

Customer Reviews
No reviews yet
TelegramWhatsApp